No abstract

No abstract

No abstract

Cancer is considered as one of the leading causes of human death worldwide. According to the National Centre for Health Statistics (NCHS), over 600,000 people have died of cancer just in the United States in 2019. Moreover, the NCHS reported that there will be approximately more than 90,000 new cases of melanoma in situ of the skin in 2020 (Siegel et al., 2019). However, the World Health Organization (WHO) has predicted that these statistics may be changed by coronavirus disease 2019 (COVID-19) outbreak in 2020.According to the WHO, 2 to 3 million cases of nonmelanoma skin cancer and more than 132,000 cases of melanomas are diagnosed annually. It has been estimated that an extra 10 percent decrease in ozone levels could lead to an additional 4,500 cases of melanoma and 300,000 cases of nonmelanoma skin cancers. Melanoma is a serious type of skin malignancies that continue to promote throughout the world especially within the white population of the United States from 1975 to 2013 (Murali et al., 2018). Furthermore, according to the National Cancer Institute reports, more than 91,000 new cases of melanoma cancer were accounted for in the United States in 2018 and more than one million Americans are living with melanoma cancer.Skin cancer is divided into two main types: nonmelanoma (keratinocyte cancer) and melanoma skin cancer. The keratinocyte cancer results from skin cells named keratinocytes and rarely spreads to other parts of the body. Keratinocyte cancer has two main subtypes including squamous cell carcinoma (SCC) and basal cell carcinoma (BCC). SCC is most common in those areas of the body that are frequently exposed to the sunlight; it also develops in the areas that do not receive sun exposure such as genitals, lips, and the mouth. BCC